Fulton Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-659
| Closed | -$216K | – | 642 |
|
|
2024
Q4 | $216K | Sell |
659
-11
| -2% | -$3.61K | 0.01% | 620 |
|
|
2024
Q3 | $224K | Buy |
+670
| New | +$224K | 0.01% | 611 |
|
|
2024
Q2 | – | Sell |
-702
| Closed | -$243K | – | 633 |
|
|
2024
Q1 | $243K | Buy |
+702
| New | +$243K | 0.01% | 550 |
|
|
2023
Q3 | – | Sell |
-559
| Closed | -$212K | – | 571 |
|
|
2023
Q2 | $212K | Sell |
559
-12
| -2% | -$4.55K | 0.01% | 522 |
|
|
2023
Q1 | $274K | Buy |
571
+76
| +15% | +$36.4K | 0.01% | 456 |
|
|
2022
Q4 | $208K | Buy |
495
+1
| +0.2% | +$420 | 0.01% | 493 |
|
|
2022
Q3 | $206K | Buy |
494
+35
| +8% | +$14.6K | 0.01% | 454 |
|
|
2022
Q2 | $227K | Sell |
459
-16
| -3% | -$7.91K | 0.01% | 438 |
|
|
2022
Q1 | $267K | Sell |
475
-65
| -12% | -$36.5K | 0.01% | 439 |
|
|
2021
Q4 | $408K | Buy |
540
+10
| +2% | +$7.56K | 0.02% | 376 |
|
|
2021
Q3 | $396K | Buy |
530
+6
| +1% | +$4.48K | 0.02% | 358 |
|
|
2021
Q2 | $338K | Buy |
524
+10
| +2% | +$6.45K | 0.02% | 373 |
|
|
2021
Q1 | $293K | Buy |
514
+66
| +15% | +$37.6K | 0.01% | 383 |
|
|
2020
Q4 | $261K | Buy |
448
+28
| +7% | +$16.3K | 0.01% | 380 |
|
|
2020
Q3 | $217K | Buy |
+420
| New | +$217K | 0.01% | 398 |
|